Biomechanical effect of crestal bone osteoplasty before implant placement: a three-dimensional finite element analysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21131179)

Published in Int J Oral Maxillofac Surg on December 04, 2010

Authors

M Hudieb1, S Kasugai

Author Affiliations

1: Department of Oral Implantology and Regenerative Dental Medicine, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. mhudeab@gmail.com

Articles by these authors

Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. Endocrinology (2001) 1.12

Regulation of osteopontin expression in osteoblasts. Ann N Y Acad Sci (1995) 1.08

Extracellular role of S100A4 calcium-binding protein in the periodontal ligament. Biochem Biophys Res Commun (1999) 1.03

Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res (2002) 1.01

Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J (1991) 1.00

Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials (1996) 0.94

Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats. Bone (1999) 0.92

Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. J Drug Target (2001) 0.91

Bone mineral density of the mandible in ovariectomized rats: analyses using dual energy X-ray absorptiometry and peripheral quantitative computed tomography. Oral Dis (2003) 0.89

Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone (2002) 0.88

Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone. Bone (1999) 0.88

Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4. Biochem Pharmacol (1997) 0.87

Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models. Jpn J Pharmacol (1999) 0.87

cDNA cloning of S100 calcium-binding proteins from bovine periodontal ligament and their expression in oral tissues. J Dent Res (1998) 0.83

Expression of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity. J Bone Miner Res (1995) 0.83

Toxicity of camphorated phenol and camphorated parachlorophenol in dental pulp cell culture. J Endod (1996) 0.82

Novel bioresorbable strontium hydroxyapatite membrane for guided bone regeneration. Clin Oral Implants Res (2013) 0.82

Behavior of bone marrow cells cultured on three different coatings of gel-derived bioactive glass-ceramics at early stages of cell differentiation. J Biomed Mater Res (1998) 0.82

Ingestion of gelatin has differential effect on bone mineral density and body weight in protein undernutrition. J Nutr Sci Vitaminol (Tokyo) (2001) 0.81

A mineralizing rat dental pulp cell subline expressing collagen type I and dentin sialoprotein-phosphophoryn transcripts. In Vitro Cell Dev Biol Anim (2002) 0.81

Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development. J Bone Miner Res (1997) 0.80

Enhanced osteoblast and osteoclast responses to a thin film sputtered hydroxyapatite coating. J Mater Sci Mater Med (2011) 0.80

Factors related to prosthetic restoration in patients with shortened dental arches: a multicentre study. J Oral Rehabil (2010) 0.79

Influence of menopause on mandibular bone quantity and quality in Japanese women receiving dental implants. Arch Osteoporos (2011) 0.78

Autoradiographic study using 3H-thymidine on rat incisal pulp cells in vitro. Bull Tokyo Med Dent Univ (1983) 0.75

Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone. Cancer Res (1999) 0.75

Effects of mechanical stress on the mRNA expression of S100A4 and cytoskeletal components by periodontal ligament cells. J Med Dent Sci (1999) 0.75

[Effect of phosphodiesterase IV inhibitors on bone tissue: a possibility for its use as a new agent to treat osteoporosis]. Kokubyo Gakkai Zasshi (1996) 0.75

Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production. Jpn J Cancer Res (1995) 0.75

An ultrastructural study of reparative dentinogenesis in the rat incisor after colchicine administration. J Electron Microsc (Tokyo) (1987) 0.75

[Differentiation of odontoblast-like cells from dental pulp cells]. Kokubyo Gakkai Zasshi (1985) 0.75

Restricted expression of chromatin remodeling associated factor Chd3 during tooth root development. J Periodontal Res (2011) 0.75

Strontium hydroxyapatite in situ gel-forming system - a new approach for minimally invasive bone augmentation. Clin Oral Implants Res (2014) 0.75

Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines. J Med Chem (1997) 0.75

The effect of glutathione on 2-hydroxyethylmethacrylate cytotoxicity and on resin-dentine bond strength. Int Endod J (2013) 0.75

Postmenopause-like bone loss by mammary carcinoma Walker256/S which secretes luteinizing hormone-releasing hormone. Jpn J Pharmacol (1999) 0.75

Heterogeneity of phenotypic and genotypic traits including organic-acid resistance in Escherichia coli O157 isolates. Microbiol Immunol (1998) 0.75